Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Form of vitamin B3 shows improvements in treating Alzheimer’s – on mouse model
February 7, 2018 Off

Form of vitamin B3 shows improvements in treating Alzheimer’s – on mouse model

By Dino Mustafić

Alzheimer’s disease can be with prevended neurological damage and improved cognitive and physical function with the supplement nicotinamide riboside (NR)…

February 6, 2018 Off

Symcel expands with new board members, aims to promote its calScreener

By Dino Mustafić

Symcel, the company that makes assay tool for real-time cell metabolism measurements, calScreener – is expanding to bring its patented…

Idorsia six months after demerger from Actelion posts €12M net loss, announces investing in pipeline and OPEX of €336M in 2018
February 6, 2018 Off

Idorsia six months after demerger from Actelion posts €12M net loss, announces investing in pipeline and OPEX of €336M in 2018

By Dino Mustafić

Idorsia Ltd has made meaningful collaboration with industry leaders in the six and a half months since the demerger from…

February 5, 2018 Off

Shield disappointed with Feraccru study results

By Dino Mustafić

Shield Therapeutics reported the results from its AEGIS-CKD pivotal Phase III study of Feraccru, a novel oral ferric iron therapy…

BMS’s study for Opdivo combination with Yervoy for non-small cell lung cancer meets endpoint
February 5, 2018 Off

BMS’s study for Opdivo combination with Yervoy for non-small cell lung cancer meets endpoint

By Dino Mustafić

Bristol-Myers Squibb said Monday that its Phase 3 CheckMate -227 study met its co-primary endpoint of progression-free survival (PFS) with…

February 5, 2018 Off

Bristol-Myers Squibb reports $2.3B net loss Q4 2017, compared to net earnings of $894M in 2016

By Dino Mustafić

The fourth quarter and full year of 2017 Bristol-Myers Squibb were highlighted by sales for Opdivo and Eliquis, in addition to regulatory and…

Premaitha gets IONA test approval in Brasil
February 5, 2018 Off

Premaitha gets IONA test approval in Brasil

By Dino Mustafić

Premaitha Health has announced that the IONA test has been approved by Brazil’s regulatory authority, Agência Nacional de Vigilância Sanitária…

February 5, 2018 Off

Alexion Pharmaceuticals welcomes new board member from data and analytics company

By Dino Mustafić

Alexion Pharmaceuticals has adde Judith A. Reinsdorf to its Board of Directors. 

February 5, 2018 Off

Canadian cannabis derivatives producer Emblem Corp’s founder leaves board of directors

By Dino Mustafić

Emblem Corp, licensed producer and distributor of medical cannabis and cannabis derivatives in Canada, said Monday that that its director…

February 5, 2018 Off

Allergan names new financial leader

By Dino Mustafić

Allergan said Monday it has named Matt Walsh, an experienced Chief Financial Officer, to lead the financial sector of the…

Posts pagination

Previous 1 … 3,407 3,408 3,409 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine